190 related articles for article (PubMed ID: 38336722)
21. Access to, Experience with, and Attitudes towards Take Home Naloxone: An Online Survey.
Schwieger L; Carpenter JE; Moran TP; Erowid F; Cornelison M; Evans D; Morgan B; Murray BP
J Community Health; 2024 Jun; 49(3):526-534. PubMed ID: 38127295
[TBL] [Abstract][Full Text] [Related]
22. Neighborhood and Individual Disparities in Community-Based Naloxone Access for Opioid Overdose Prevention.
Nesoff ED; Meisel ZF; Saeed H; Martins SS
J Urban Health; 2024 Feb; 101(1):64-74. PubMed ID: 38196059
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids.
Winhusen T; Wilder C; Lyons MS; Theobald J; Kropp F; Lewis D
Drug Alcohol Depend; 2020 Nov; 216():108265. PubMed ID: 32919098
[TBL] [Abstract][Full Text] [Related]
24. A randomized clinical trial of the effects of brief versus extended opioid overdose education on naloxone utilization outcomes by individuals with opioid use disorder.
Jones JD; Campbell AN; Brandt L; Metz VE; Martinez S; Wall M; Corbeil T; Andrews H; Castillo F; Neale J; Strang J; Ross S; Comer SD
Drug Alcohol Depend; 2022 Aug; 237():109505. PubMed ID: 35709575
[TBL] [Abstract][Full Text] [Related]
25. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
[TBL] [Abstract][Full Text] [Related]
26. High occurrence of witnessing an opioid overdose in a sample of women who use heroin in Tanzania: Implications for overdose prevention.
Saleem HT; Likindikoki S; Nonyane BAS; Mbwambo J; Latkin C
Int J Drug Policy; 2021 Oct; 96():103287. PubMed ID: 33994309
[TBL] [Abstract][Full Text] [Related]
27. Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City.
Khan MR; Hoff L; Elliott L; Scheidell JD; Pamplin JR; Townsend TN; Irvine NM; Bennett AS
Harm Reduct J; 2023 Feb; 20(1):24. PubMed ID: 36841763
[TBL] [Abstract][Full Text] [Related]
28. Preliminary effectiveness of online opioid overdose and naloxone administration training and impact of naloxone possession on opioid use.
Sisson ML; Azuero A; Chichester KR; Carpenter MJ; Businelle MS; Shelton RC; Cropsey KL
Drug Alcohol Depend; 2023 Aug; 249():110815. PubMed ID: 37336007
[TBL] [Abstract][Full Text] [Related]
29. A qualitative examination of naloxone access in three states: Connecticut, Kentucky, and Wisconsin.
Spector AL; Galletly CL; Christenson EA; Montaque HDG; Dickson-Gomez J
BMC Public Health; 2022 Jul; 22(1):1387. PubMed ID: 35854278
[TBL] [Abstract][Full Text] [Related]
30. Lay responder naloxone access and Good Samaritan law compliance: postcard survey results from 20 Indiana counties.
Watson DP; Ray B; Robison L; Huynh P; Sightes E; Walker S; Brucker K; Duwve J
Harm Reduct J; 2018 Apr; 15(1):18. PubMed ID: 29625609
[TBL] [Abstract][Full Text] [Related]
31. Association of Fentanyl Test Strip Use, Perceived Overdose Risk, and Naloxone Possession among People Who Use Drugs.
Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
Subst Use Misuse; 2024; 59(2):254-257. PubMed ID: 37807227
[No Abstract] [Full Text] [Related]
32. Patient perceptions of higher-dose naloxone nasal spray for opioid overdose.
Strickland JC; Marks KR; Smith KE; Ellis JD; Hobelmann JG; Huhn AS
Int J Drug Policy; 2022 Aug; 106():103751. PubMed ID: 35636070
[TBL] [Abstract][Full Text] [Related]
33. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
McDonald R; Campbell ND; Strang J
Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
[TBL] [Abstract][Full Text] [Related]
34. Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply.
Tse WC; Djordjevic F; Borja V; Picco L; Lam T; Olsen A; Larney S; Dietze P; Nielsen S
Int J Drug Policy; 2022 Feb; 100():103513. PubMed ID: 34798434
[TBL] [Abstract][Full Text] [Related]
35. Naloxone Use Among Emergency Department Patients with Opioid Overdose.
Marco CA; Trautman W; Cook A; Mann D; Rasp J; Perkins O; Ballester M
J Emerg Med; 2018 Jul; 55(1):64-70. PubMed ID: 29776702
[TBL] [Abstract][Full Text] [Related]
36. Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019.
Quinn K; Kumar S; Hunter CT; O'Donnell J; Davis NL
Drug Alcohol Depend; 2022 Jun; 235():109467. PubMed ID: 35461083
[TBL] [Abstract][Full Text] [Related]
37. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
[TBL] [Abstract][Full Text] [Related]
38. Opioid Misuse Harm Reduction.
Bailey NR; Mitchell KA; Miller TM
J Addict Nurs; 2024 Jan-Mar 01; 35(1):3-14. PubMed ID: 38373177
[TBL] [Abstract][Full Text] [Related]
39. Practical implications of naloxone knowledge among suburban people who use opioids.
Schneider KE; Urquhart GJ; Rouhani S; Park JN; Morris M; Allen ST; Sherman SG
Harm Reduct J; 2021 Apr; 18(1):47. PubMed ID: 33910565
[TBL] [Abstract][Full Text] [Related]
40. Designing a public access naloxone program for public transportation stations.
Kohli S; Garg J; Velasquez DE; Weiner SG
Healthc (Amst); 2023 Jun; 11(2):100694. PubMed ID: 37247465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
